Treatment utility can be defined as a combination of objective clinical efficacy and quality-of-life results (i.e. subjective criteria). It is a particularly useful concept in diseases such as benign prostatic hyperplasia where important differences may exist between the results of objective measurements and the assessment of subjective complaints and quality-of-life impairment. The collection of data regarding treatment utility involves the generation of large patient care databases which provide long-term data in representative, general practice, patient populations. Such data provide overall information for physicians,health care providers, patients, insurance companies and health care decision-makers and enable them to define the long-term effectiveness of each treatment. In addition, predictive or risk factors which may assist in appropriate clinical decision-making may be identified. Such data also provide cost/utility information. Finally, the data could be used in daily practice to allow the physician to make rapid therapeutic decisions.

Keywords:
Benign prostatic hyperplasia, Alfuzosin, Quality of life, Database, Safety
This content is only available via PDF.
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.